PharmaEssentia Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	24,471	22,693	21,051	19,666	10,304	3,454
Short-Term Investments	-	0.43	-	-	-	-
Cash & Short-Term Investments	24,471	22,693	21,051	19,666	10,304	3,454
Cash Growth	17.75%	7.80%	7.04%	90.86%	198.34%	7.51%
Accounts Receivable	5,634	4,472	2,624	1,312	798.87	466.04
Other Receivables	215.27	176.79	210.67	236.08	41.22	27.17
Receivables	5,849	4,649	2,834	1,548	840.09	493.22
Inventory	1,314	1,328	1,287	1,459	1,102	861.38
Prepaid Expenses	689.3	306.35	163.58	151.92	55.64	49.02
Other Current Assets	1,265	67.05	80.96	71.18	1,074	69.41
Total Current Assets	33,589	29,044	25,417	22,896	13,375	4,927
Property, Plant & Equipment	5,819	4,902	3,361	2,733	1,018	764.93
Long-Term Investments	427.84	461.44	542.44	163.92	43.24	39.22
Other Intangible Assets	430.93	235.12	272.72	267.91	236.88	246.25
Long-Term Deferred Tax Assets	1,798	1,693	1,120	958.46	483.42	-
Other Long-Term Assets	1,166	1,076	347.95	249.72	176.38	221.13
Total Assets	44,111	37,411	31,062	27,269	15,333	6,198
Accounts Payable	337.38	156.73	126.47	128.88	230.96	176.38
Accrued Expenses	1,262	1,736	1,106	970.52	667.45	405.5
Short-Term Debt	-	-	-	21	993.88	20
Current Portion of Long-Term Debt	5.98	5.98	11.9	12.36	12.14	12.05
Current Portion of Leases	199.59	202.31	180.56	211.85	77.76	78.59
Current Income Taxes Payable	843.65	266.54	-	0.99	-	-
Current Unearned Revenue	12.25	-	0.23	-	-	-
Other Current Liabilities	3,703	2,313	1,132	806.49	568.16	719.44
Total Current Liabilities	6,364	4,681	2,557	2,152	2,550	1,412
Long-Term Debt	41.85	44.83	50.81	62.71	74.98	87.09
Long-Term Leases	774.5	602.91	722.16	892.29	410.05	338.51
Pension & Post-Retirement Benefits	11.11	10.38	11.06	10.21	4.18	3.95
Long-Term Deferred Tax Liabilities	88.83	84.37	81.32	105.96	8.22	-
Other Long-Term Liabilities	14.71	12.76	170.21	97.91	143.64	106.3
Total Liabilities	7,295	5,436	3,593	3,321	3,191	1,948
Common Stock	3,816	3,796	3,418	3,403	3,025	2,769
Additional Paid-In Capital	25,410	24,106	23,547	24,092	13,421	4,697
Retained Earnings	10,550	7,244	2,974	-631.19	-4,186	-2,811
Treasury Stock	-2,718	-2,763	-2,805	-2,805	-87.5	-344.74
Comprehensive Income & Other	-242.44	-408.75	335.89	-110.37	-31.54	-60.15
Shareholders' Equity	36,816	31,975	27,469	23,948	12,141	4,250
Total Liabilities & Equity	44,111	37,411	31,062	27,269	15,333	6,198
Total Debt	1,022	856.03	965.43	1,200	1,569	536.24
Net Cash (Debt)	23,449	21,837	20,086	18,466	8,735	2,917
Net Cash Growth	18.20%	8.72%	8.77%	111.40%	199.41%	13.71%
Net Cash Per Share	56.86	53.04	48.85	46.52	24.97	9.11
Filing Date Shares Outstanding	414.43	411.72	409.78	407.9	371.21	336.14
Total Common Shares Outstanding	414.43	411.72	409.78	407.9	371.21	336.14
Working Capital	27,225	24,363	22,860	20,744	10,825	3,515
Book Value Per Share	88.84	77.66	67.03	58.71	32.71	12.64
Tangible Book Value	35,506	31,740	27,196	23,680	11,904	4,004
Tangible Book Value Per Share	85.67	77.09	66.37	58.05	32.07	11.91
Land	132.09	58.24	58.24	58.24	58.24	58.24
Buildings	280.01	69.82	70.86	70.63	70.61	70.52
Machinery	1,291	1,175	811.38	723.26	534.93	486.58
Construction In Progress	3,507	3,072	2,011	1,188	234.56	36.49
Leasehold Improvements	758.08	754.58	429.87	426.29	371.12	341.61